Can scans replace breathing tests to monitor lung scarring?
NCT ID NCT05492994
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study follows 31 people with progressive fibrosing interstitial lung disease (PF-ILD) for one year. Researchers compare imaging scans (CT and MRI) with standard breathing tests to see which method best tracks lung damage over time. The goal is to find better ways to measure disease progression for use in future drug trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help develop better imaging tools to monitor lung disease progression and improve future clinical trials.
What could go wrong
This is a small observational study, not a treatment trial. The imaging methods may not prove more useful than standard lung function tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- SCB0020160 First-in-Human Safety Trial (NCT07682337)
- MNKD-201 for IPF: Phase 2 Trial of Inhaled Ninte NCT07679893
- Beetroot Juice for IPF Exercise Capacity – NCT06488638
- STRIVE II: Plasma Exchange & Rituximab for IPF (NCT07674745)
- Edinburgh Lung Fibrosis Study NCT04016181
- Nalbuphine ER for Cough in IPF Trial (NCT05964335)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medizinische Hochschule Hannover
Hanover, 30625, Germany